Currently, there are 166.66M common shares owned by the public and among those 165.20M shares have been available to trade.
However, the script later moved the day high at 15.65, down -1.41%. The company’s stock has a 5-day price change of 6.81% and -19.99% over the past three months. TDOC shares are trading -28.68% year to date (YTD), with the 12-month market performance down to -34.68% lower. It has a 12-month low price of $14.29 and touched a high of $30.41 over the same period. TDOC has an average intraday trading volume of 4.86 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -8.33%, -19.43%, and -26.37% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Teladoc Health Inc (NYSE: TDOC) shares accounts for 77.43% of the company’s 166.66M shares outstanding.
It has a market capitalization of $2.57B and a beta (3y monthly) value of 0.94. The earnings-per-share (ttm) stands at -$1.34. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.48% over the week and 4.08% over the month.
Analysts forecast that Teladoc Health Inc (TDOC) will achieve an EPS of -$0.45 for the current quarter, -$0.3 for the next quarter and -$0.71 for 2025. The lowest estimate earnings-per-share for the quarter is -$0.54 while analysts give the company a high EPS estimate of -$0.28. Comparatively, EPS for the current quarter was -$0.42 a year ago. Earnings per share for the fiscal year are expected to increase by 21.84%, and 31.62% over the next financial year.
Looking at the support for the TDOC, a number of firms have released research notes about the stock. Cantor Fitzgerald stated their Overweight rating for the stock in a research note on February 29, 2024, with the firm’s price target at $22. Leerink Partners coverage for the Teladoc Health Inc (TDOC) stock in a research note released on February 26, 2024 offered a Market Perform rating with a price target of $17. DA Davidson was of a view on January 17, 2024 that the stock is Neutral, while Barclays gave the stock Overweight rating on January 03, 2024, issuing a price target of $26. Stephens on their part issued Equal-Weight rating on April 12, 2023.
